{"schema_version":"secwatch.filing_event.v1","accession":"0001370053-23-000043","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.591073+00:00","generated_at":"2026-06-13T23:55:40.144225+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AnaptysBio shareholders elect three directors, ratify KPMG, approve executive pay, and amend charter","bullets":["Elected Magda Marquet (21.6M for), Hollings Renton (16.9M for), John P. Schmid (20.4M for) as Class III directors for three-year terms.","Ratified KPMG LLP as independent auditor for FY2023 with 24.5M for, 203K against.","Approved non-binding advisory say-on-pay with 15.2M for, 7.2M against.","Approved amended certificate of incorporation to permit officer exculpation with 21.8M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001370053-23-000043","json":"https://secwatch.observer/filing/0001370053-23-000043.json","markdown":"https://secwatch.observer/filing/0001370053-23-000043.md","text":"https://secwatch.observer/filing/0001370053-23-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000043/0001370053-23-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000043/anab-20230615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:55:40.144225+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"190a2d4a4cb381d954e2d871228d783a71ced3f3","claim":"ANAPTYSBIO, INC shareholders approved Non-binding, advisory approval of compensation paid to the Company's named executive officers at the 2023-06-15 meeting.","evidence_excerpt":"3. Non-binding, advisory approval of compensation paid to the Company’s named executive officers: Shares For Shares Against Shares Withheld/Abstaining Broker Non-Votes 15,221,869 7,185,726 2,237 2,247,178","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000043/0001370053-23-000043-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"68097aeb4e7afcbad327208789ccbebb8ec642ad","claim":"ANAPTYSBIO, INC shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.","evidence_excerpt":"2. Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: Shares For Shares Against Shares Withheld/Abstaining Broker Non-Votes 24,453,643 203,193 174 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000043/0001370053-23-000043-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"c90fd8d8afb8b86faff164b3d0006f6fc0538b84","claim":"ANAPTYSBIO, INC shareholders approved Election of three Class III directors, Magda Marquet, Ph.D., Hollings Renton, M.B.A., and John P. Schmid, each to serve a three-year term at the 2023-06-15 meeting.","evidence_excerpt":"1. Election of three Class III directors, Magda Marquet, Ph.D., Hollings Renton, M.B.A., and John P. Schmid, each to serve a three-year term, which will expire at the 2026 Annual Meeting of Stockholders or until such time as his or her respective successor has been duly elected and qualified or until such director’s earlier resignation or removal: Nominees Shares For Shares Withheld / Abstaining Broker Non-Votes Magda Marquet, Ph.D. 21,553,117 856,715 2,247,178 Hollings Renton, M.B.A. 16,883,226 5,526,606 2,247,178 John P. Schmid 20,391,333 2,018,499 2,247,178","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000043/0001370053-23-000043-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"ca2f22144c3d5ba11940067709872e597ac09282","claim":"ANAPTYSBIO, INC shareholders approved Approval of the Amended and Restated Certificate of Incorporation permitting the exculpation of officers at the 2023-06-15 meeting.","evidence_excerpt":"4. Approval of the Amended and Restated Certificate of Incorporation permitting the exculpation of officers: Shares For Shares Against Shares Withheld/Abstaining Broker Non-Votes 21,803,870 605,555 407 2,247,178","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000043/0001370053-23-000043-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}